Alitair: Alitair Announces Issuance of Patent Covering Its Prescription Drug Overdose Reduction Technology ODR

Alitair Pharmaceuticals Inc. a clinical stage pharmaceutical company focused on respiratory health today announced the issuance of U.S. Patent No. 9211292 covering its prescription drug overdose reduction technology ODR . ODR is des...